Walleye Trading
MRNA icon

Walleye Trading’s Moderna MRNA Stock Holding History

Walleye Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.08M Buy
101,066
+93,809
+1,293% +$4.85M 0.01% 1109
2026
Q1 		$369K Sell
7,257
-316,376
-98% -$14.8M ﹤0.01% 2764
2025
Q4 		$9.54M Sell
323,633
-60,256
-16% -$1.64M 0.01% 948
2025
Q3 		$9.92M Buy
383,889
+120,073
+46% +$3.35M 0.02% 901
2025
Q2 		$7.28M Sell
263,816
-78,481
-23% -$2.07M 0.01% 981
2025
Q1 		$9.7M Buy
342,297
+234,925
+219% +$8.34M 0.02% 746
2024
Q4 		$4.46M Buy
+107,372
New +$5.13M 0.01% 1226
2024
Q3 		– Sell
-60,433
Closed -$5.55M – 4417
2024
Q2 		$7.18M Buy
60,433
+9,822
+19% +$1.24M 0.02% 860
2024
Q1 		$5.39M Buy
50,611
+34,133
+207% +$3.44M 0.01% 1075
2023
Q4 		$1.64M Sell
16,478
-42,483
-72% -$3.57M ﹤0.01% 2077
2023
Q3 		$6.09M Buy
58,961
+43,157
+273% +$4.81M 0.02% 973
2023
Q2 		$1.92M Buy
+15,804
New +$2.11M 0.01% 1680
2023
Q1 		– Sell
-14,696
Closed -$2.42M – 5180
2022
Q4 		$2.64M Buy
14,696
+7,469
+103% +$1.22M 0.01% 1497
2022
Q3 		$855K Buy
+7,227
New +$1.1M ﹤0.01% 2384
2022
Q2 		– Sell
-4,749
Closed -$679K – 5477
2022
Q1 		$818K Sell
4,749
-86,653
-95% -$14.6M ﹤0.01% 2419
2021
Q4 		$23.2M Buy
91,402
+26,407
+41% +$7.72M 0.08% 271
2021
Q3 		$25M Buy
+64,995
New +$24M 0.09% 216
2021
Q2 		– Sell
-44,017
Closed -$7.87M – 5400
2021
Q1 		$5.76M Buy
+44,017
New +$6.38M 0.03% 568
2020
Q3 		– Sell
-13,843
Closed -$965K – 4427
2020
Q2 		$889K Sell
13,843
-42,916
-76% -$2.35M 0.01% 1767
2020
Q1 		$1.7M Buy
+56,759
New +$1.31M 0.01% 950
2019
Q3 		– Sell
-2,985
Closed -$44.1K – 4288
2019
Q2 		$44K Buy
+2,985
New +$64.1K ﹤0.01% 3586

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Walleye Trading's MRNA Position: Q2 2026 in Review

Walleye Trading increased its Moderna (MRNA) stake by 1,293% in Q2 2026, buying an estimated $4.85M and bringing the position to 101,066 shares worth $7.08M. The position accounts for 0.01% of the portfolio, ranked #1109.

Walleye Trading first reported a position in MRNA in Q2 2019 and has held it in 21 quarters since. The position peaked at $25M in Q3 2021. 399 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Walleye Trading held 101,066 shares of Moderna worth $7.08M as of Q2 2026.
  • Walleye Trading bought 93,809 Moderna shares in Q2 2026, an estimated $4.85M.
  • Moderna made up 0.01% of Walleye Trading's portfolio in Q2 2026, its #1109 holding.
  • Walleye Trading first reported a position in Moderna in Q2 2019 and has held it in 21 quarters since.
  • Walleye Trading's Moderna position peaked at $25M in Q3 2021.
  • 399 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.